Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 539
5
Diseases
13
Unique genes
0.278
Avg. similarity score
Antley-bixler syndrome with genital anomalies and disordered steroidogenesis
Most-connected disease (4 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Antley-bixler syndrome with genital anomalies and disordered steroidogenesis
Disordered steroidogenesis due to cytochrome p450 oxidoreductase
P450 oxidoreductase deficiency
Antley-bixler syndrome
Congenital adrenal hyperplasia
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Antley-bixler syndrome with genital anomalies and disordered steroidogenesis | 4 | 4 | 1 |
| Disordered steroidogenesis due to cytochrome p450 oxidoreductase | 4 | 4 | 1 |
| P450 oxidoreductase deficiency | 4 | 4 | 1 |
| Antley-bixler syndrome | 3 | 3 | 3 |
| Congenital adrenal hyperplasia | 3 | 3 | 11 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| POR | 5 / 5 | Antley-bixler syndrome, Antley-bixler syndrome with genital anomalies and disordered steroidogenesis, Congenital adrenal hyperplasia, Disordered steroidogenesis due to cytochrome p450 oxidoreductase and 1 more |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Cortisol synthesis and secretion | KEGG | 7 / 65 | 99.5× | 1.63e-13 | 3.61e-11 ✓ sig. |
| Steroid hormone biosynthesis | KEGG | 6 / 63 | 88.0× | 2.72e-11 | 3.76e-9 ✓ sig. |
| Glucocorticoid biosynthesis | Reactome | 4 / 10 | 370× | 1.73e-10 | 1.90e-8 ✓ sig. |
| Ovarian steroidogenesis | KEGG | 5 / 52 | 88.8× | 1.57e-9 | 1.39e-7 ✓ sig. |
| Cushing syndrome | KEGG | 6 / 155 | 35.8× | 6.68e-9 | 5.16e-7 ✓ sig. |
| Endogenous sterols | Reactome | 4 / 25 | 148× | 1.03e-8 | 7.61e-7 ✓ sig. |
| Aldosterone synthesis and secretion | KEGG | 4 / 98 | 37.7× | 2.82e-6 | 1.01e-4 ✓ sig. |
| Mineralocorticoid biosynthesis | Reactome | 2 / 6 | 308× | 1.62e-5 | 4.36e-4 ✓ sig. |
| Androgen biosynthesis | Reactome | 2 / 11 | 168× | 5.92e-5 | 1.25e-3 ✓ sig. |
| Pregnenolone biosynthesis | Reactome | 2 / 12 | 154× | 7.10e-5 | 1.44e-3 ✓ sig. |
| Defective CYP11B1 causes Adrenal hyperplasia 4 (AH4) | Reactome | 1 / 1 | 924× | 1.08e-3 | 1.20e-2 ✓ sig. |
| Defective CYP17A1 causes Adrenal hyperplasia 5 (AH5) | Reactome | 1 / 1 | 924× | 1.08e-3 | 1.20e-2 ✓ sig. |
| Defective CYP19A1 causes Aromatase excess syndrome (AEXS) | Reactome | 1 / 1 | 924× | 1.08e-3 | 1.20e-2 ✓ sig. |
| Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3) | Reactome | 1 / 1 | 924× | 1.08e-3 | 1.20e-2 ✓ sig. |
| Signaling by FGFR2 amplification mutants | Reactome | 1 / 1 | 924× | 1.08e-3 | 1.20e-2 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| steroid biosynthetic process | GO:0006694 | 7 / 65 | 155× | 7.45e-15 | 5.19e-12 ✓ sig. |
| glucocorticoid biosynthetic process | GO:0006704 | 4 / 7 | 821× | 4.92e-12 | 2.01e-9 ✓ sig. |
| sterol metabolic process | GO:0016125 | 4 / 22 | 261× | 1.02e-9 | 2.37e-7 ✓ sig. |
| cortisol biosynthetic process | GO:0034651 | 3 / 5 | 862× | 2.63e-9 | 5.42e-7 ✓ sig. |
| lipid metabolic process | GO:0006629 | 8 / 840 | 13.7× | 1.70e-8 | 2.79e-6 ✓ sig. |
| cellular response to peptide hormone stimulus | GO:0071375 | 3 / 18 | 240× | 2.13e-7 | 2.38e-5 ✓ sig. |
| cortisol metabolic process | GO:0034650 | 2 / 4 | 719× | 2.68e-6 | 1.92e-4 ✓ sig. |
| C21-steroid hormone biosynthetic process | GO:0006700 | 2 / 5 | 575× | 4.46e-6 | 2.89e-4 ✓ sig. |
| C21-steroid hormone metabolic process | GO:0008207 | 2 / 7 | 411× | 9.36e-6 | 5.17e-4 ✓ sig. |
| androgen biosynthetic process | GO:0006702 | 2 / 9 | 319× | 1.60e-5 | 7.84e-4 ✓ sig. |
| cholesterol metabolic process | GO:0008203 | 3 / 107 | 40.3× | 5.01e-5 | 1.85e-3 ✓ sig. |
| alcohol metabolic process | GO:0006066 | 2 / 18 | 160× | 6.79e-5 | 2.32e-3 ✓ sig. |
| steroid metabolic process | GO:0008202 | 3 / 135 | 31.9× | 1.00e-4 | 3.10e-3 ✓ sig. |
| regulation of cell differentiation | GO:0045595 | 2 / 54 | 53.2× | 6.26e-4 | 1.11e-2 ✓ sig. |
| positive regulation of cell fate determination | GO:1905935 | 1 / 1 | 1,437× | 6.96e-4 | 1.18e-2 ✓ sig. |